Quantum量子訊息有限公司
← 最新全球產業報告

Regenerative Artificial Skin Market

研究執行與發布:Coherent Market Insights · 發布日期 2026-01-14 · 141 頁
由量子訊息有限公司(Quantum Information)在台灣代理銷售與提供授權諮詢。

2026 年市場規模
USD 3,084.9 Mn
2033 年預估規模
USD 5,980.0 Mn
年複合成長率 CAGR
9.9%

以上數字由 Coherent Market Insights 於本報告中提出,量子訊息原樣引用。

出版商 Coherent Market Insights產業別 Medical Devices出版日期 2026-01-14頁數 141報告編號 CMI100

授權報價

Single User Price$4,500 USD
Enterprise License$10,000 USD
洽詢購買 申請 Sample
完整報告名稱與涵蓋範圍
Regenerative Artificial Skin Market, By Material Type (Biological (Natural) Materials, Synthetic Polymers, Composite Materials, StemCell Based Constructs, Autologous, and Allogeneic & Xenogeneic Sources), By Product Type (Acellular Skin Substitutes, Cellular Skin Substitutes, Composite Skin Substitutes, Bioengineered Skin, Synthetic Skin, and Hydrogelbased Skin), By Application (Burn Treatment & Management, Chronic Wound Healing, Trauma & Injury Repair, Reconstructive & Plastic Surgery, Dermatology & Cosmetic Uses, and Others), By End User (Hospitals, Burn Care Centers, Clinics, and Ambulatory Surgical Centers (ASCs)), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

報告摘要

The regenerative artificial skin market is expected to grow significantly, having an estimated valuation of USD 3,084.9 Mn in 2026 and is expected to reach USD 5,980.0 Mn by 2033, with a CAGR of 9.9% during the forecast period. The market observes strong growth due to the rising incidence of chronic wounds, injuries from burns, surgical trauma, and other skin disorders. Solutions for regenerative artificial skin, such as bioengineered and cellular skin substitutes, thus assure better wound healing, less risk of infection, and restoration of function in damaged tissues. Regenerative artificial skin refers to engineered skin constructs developed using biological, synthetic, or composite materials. These constructs may be acellular, cellular, or bioengineered to replicate the structure and function of human skin. This technology combines advanced biomaterials and stem cell technology with principles of tissue engineering to provide accelerated healing, integration, and restoration of both physical and sensory functions lost due to damaged skin. With increased usage in hospitals and clinics, regenerative artificial skin has become an important element in advanced wound care. Market Dynamics The regenerative artificial skin market is experiencing significant growth driven by the rising prevalence of chronic wounds, burns, and trauma-related injuries, along with increasing surgical procedures and growing awareness of advanced wound care technologies. Healthcare providers, particularly hospitals and burn centers, are increasingly adopting regenerative skin substitutes to improve clinical outcomes, reduce recovery time, and minimize complications. Advanced solutions for wound care, including bioengineered and stem-cell-based products, are gaining greater preference due to their superior clinical performance and enhancement of patient recovery. Innovation in product development is a major factor shaping the market dynamics. Multi-layered bioengineered skin constructs resemble biological tissue structure, providing better healing and lower infection rates. Stem-enhanced technologies promote faster healing and better integration of the grafts. 3D bioprinting technologies provide patient-specific skin grafts that incorporate better cellular structure for effective results in reconstruction and burns surgeries. Smart dressings with biosensing and biologic agent delivery for real-time results of healing and infection detection and delivery of medications contribute to better results. Green materials like plant and fish skin scaffolds are being introduced as biologically and functionally stable materials that provide effective results with sustainable materials and processes for patients with wounds. Technological breakthroughs are further transforming the regenerative artificial skin landscape. The maturation of 3D bioprinting enhances commercial viability and reduces production costs. CRISPR gene editing allows the production of bespoke skin substitutes with improved healing properties and reduces the incidence of rejection. But international trade restrictions on biotechnology materials and intellectual property disputes are compromising supply chains and collaborations in research globally, adding a layer of uncertainty to market operations. Overall, continuous innovation, increasing clinical adoption, and the integration of regenerative therapies into mainstream medical practice continue to drive growth in the market. Companies focused on clinically validated, functional, and cost-effective skin substitutes are better placed to tap into the dynamic and transformative segment of healthcare. Key Features of the Study • This report provides in-depth analysis of the regenerative artificial skin market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2026-2033), considering 2025 as the base year • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players • It profiles key players in the regenerative artificial skin market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies • Key companies covered as a part of this study include, Integra LifeSciences Corporation, Smith & Nephew plc, Organogenesis Inc., MiMedx Group, Avita Medical, Stratatech, Vericel Corporation, B. Braun Melsungen AG, Kerecis, PolarityTE, Tissue Regenix Group plc, and Celularity. • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics • The regenerative artificial skin market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the regenerative artificial skin Market Market Segmentation • Material Type Insights (Revenue, USD Mn, 2026 - 2033) o Biological Materials o Synthetic Polymers o Composite Materials o Stem Cell Based Constructs o Autologous o Allogeneic & Xenogeneic Sources • Product Type Insights (Revenue, USD Mn, 2026 - 2033) o Acellular Skin Substitutes o Cellular Skin Substitutes o Composite Skin Substitutes o Bioengineered Skin o Synthetic Skin o Hydrogel based Skin • Application Insights (Revenue, USD Mn, 2026 - 2033) o Burn Treatment & Management o Chronic Wound Healing o Trauma & Injury Repair o Reconstructive & Plastic Surgery o Dermatology & Cosmetic Uses o Others • End User Insights (Revenue, USD Mn, 2026 - 2033) o Hospitals o Burn Care Centers o Clinics o Ambulatory Surgical Centers (ASCs) • Regional Insights (Revenue, USD Mn, 2026 - 2033) o North America  U.S.  Canada o Latin America  Brazil  Argentina  Mexico  Rest of Latin America o Europe  Germany  U.K.  Spain  France  Italy  Russia  Rest of Europe o Asia Pacific  China  India  Japan  Australia  South Korea  ASEAN  Rest of Asia Pacific o Middle East  GCC Countries  Israel  Rest of Middle East o Africa  South Africa  North Africa  Central Africa • Key Players Insights o Integra LifeSciences Corporation o Smith & Nephew plc o Organogenesis Inc. o MiMedx Group, Inc. o Avita Medical, Inc. o Stratatech (a Mallinckrodt Company) o Vericel Corporation o Braun Melsungen AG o Kerecis (Coloplast subsidiary) o PolarityTE, Inc. o Tissue Regenix Group plc o Celularity
目錄 Table of Contents
Table of Contents 1. Research Objectives and Assumptions o Research Objectives o Assumptions o Abbreviations 2. Market Purview o Report Description  Market Definition and Scope o Executive Summary  Market Snippet, By Material Type  Market Snippet, By Product Type  Market Snippet, By Application  Market Snippet, By End User  Market Snippet, By Region o Coherent Opportunity Map (COM) 3. Market Dynamics, Regulations, and Trends Analysis o Market Dynamics  Drivers  Restraints  PEST Analysis  PORTER’s Five Forces Analysis  Market Opportunities  Regulatory Scenario  Key Developments  Industry Trend 4. Global Regenerative Artificial Skin Market, By Material Type, 2026-2033, (USD Mn) o Introduction  Market Share Analysis, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, 2021 - 2033  Segment Trends o Biological Materials  Market Share Analysis, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, 2021 – 2033  Segment Trends o Synthetic Polymers  Market Share Analysis, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, 2021 – 2033  Segment Trends o Composite Materials  Market Share Analysis, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, 2021 - 2033  Segment Trends o StemCell Based Constructs  Market Share Analysis, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, 2021 – 2033  Segment Trends o Autologous  Market Share Analysis, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, 2021 – 2033  Segment Trends o Allogeneic & Xenogeneic Sources  Market Share Analysis, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, 2021 - 2033  Segment Trends 5. Global Regenerative Artificial Skin Market, By Product Type, 2026-2033, (USD Mn) o Introduction  Market Share Analysis, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, 2021 - 2033  Segment Trends o Acellular Skin Substitutes  Market Share Analysis, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, 2021 – 2033  Segment Trends o Cellular Skin Substitutes  Market Share Analysis, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, 2021 – 2033  Segment Trends o Composite Skin Substitutes  Market Share Analysis, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, 2021 – 2033  Segment Trends o Bioengineered Skin  Market Share Analysis, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, 2021 – 2033  Segment Trends o Synthetic Skin  Market Share Analysis, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, 2021 – 2033  Segment Trends o Hydrogelbased Skin  Market Share Analysis, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, 2021 – 2033  Segment Trends 6. Global Regenerative Artificial Skin Market, By Application, 2026-2033, (USD Mn) o Introduction  Market Share Analysis, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, 2021 - 2033  Segment Trends o Burn Treatment & Management  Market Share Analysis, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, 2021 – 2033  Segment Trends o Chronic Wound Healing  Market Share Analysis, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, 2021 – 2033  Segment Trends o Trauma & Injury Repair  Market Share Analysis, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, 2021 – 2033  Segment Trends o Reconstructive & Plastic Surgery  Market Share Analysis, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, 2021 – 2033  Segment Trends o Dermatology & Cosmetic Uses  Market Share Analysis, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, 2021 – 2033  Segment Trends o Others  Market Share Analysis, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, 2021 – 2033  Segment Trends 7. Global Regenerative Artificial Skin Market, By End User, 2026-2033, (USD Mn) o Introduction  Market Share Analysis, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, 2021 - 2033  Segment Trends o Hospitals  Market Share Analysis, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, 2021 – 2033  Segment Trends o Burn Care Centers  Market Share Analysis, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, 2021 – 2033  Segment Trends o Clinics  Market Share Analysis, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, 2021 – 2033  Segment Trends o Ambulatory Surgical Centers (ASCs)  Market Share Analysis, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, 2021 – 2033  Segment Trends 8. Global Regenerative Artificial Skin Market, By Region, 2026-2033, (USD Mn) o Introduction  Market Share Analysis, By Region, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, For Region, 2021 - 2033 o North America  Market Share Analysis, By Country, 2025, 2028 and 2033 (%)  Y-o-Y Growth Analysis, For Country, 2021 - 2033  Market Size and Forecast, By Material Type, 2026- 2033, (USD Mn)  Market Size and Forecast, By Product Type, 2026- 2033, (USD Mn)  Market Size and Forecast, By Application, 2026- 2033, (USD Mn)  Market Size and Forecast, By End User, 2026- 2033, (USD Mn)  Market Size and Forecast, By Country, 2026- 2033, (USD Mn) o U.S. o Canada o Latin America  Market Share Analysis, By Country, 2025, 2028 and 2033 (%)  Y-o-Y Growth Analysis, For Country, 2021 - 2033  Market Size and Forecast, By Material Type, 2026- 2033, (USD Mn)  Market Size and Forecast, By Product Type, 2026- 2033, (USD Mn)  Market Size and Forecast, By Application, 2026- 2033, (USD Mn)  Market Size and Forecast, By End User, 2026- 2033, (USD Mn)  Market Size and Forecast, By Country, 2026- 2033, (USD Mn) o Brazil o Argentina o Mexico o Rest of Latin America o Europe  Market Share Analysis, By Country, 2025, 2028 and 2033 (%)  Y-o-Y Growth Analysis, For Country, 2021 - 2033  Market Size and Forecast, By Material Type, 2026- 2033, (USD Mn)  Market Size and Forecast, By Product Type, 2026- 2033, (USD Mn)  Market Size and Forecast, By Application, 2026- 2033, (USD Mn)  Market Size and Forecast, By End User, 2026- 2033, (USD Mn)  Market Size and Forecast, By Country, 2026- 2033, (USD Mn) o U.K. o Germany o Italy o France o Spain o Russia o Rest of Europe o Asia Pacific  Market Share Analysis, By Country, 2025, 2028 and 2033 (%)  Y-o-Y Growth Analysis, For Country, 2021 - 2033  Market Size and Forecast, By Material Type, 2026- 2033, (USD Mn)  Market Size and Forecast, By Product Type, 2026- 2033, (USD Mn)  Market Size and Forecast, By Application, 2026- 2033, (USD Mn)  Market Size and Forecast, By End User, 2026- 2033, (USD Mn)  Market Size and Forecast, By Country, 2026- 2033, (USD Mn) o China o India o Japan o ASEAN o Australia o South Korea o Rest of Asia Pacific o Middle East  Market Share Analysis, By Country, 2025, 2028 and 2033 (%)  Y-o-Y Growth Analysis, For Country, 2021 - 2033  Market Size and Forecast, By Material Type, 2026- 2033, (USD Mn)  Market Size and Forecast, By Product Type, 2026- 2033, (USD Mn)  Market Size and Forecast, By Application, 2026- 2033, (USD Mn)  Market Size and Forecast, By End User, 2026- 2033, (USD Mn)  Market Size and Forecast, By Country, 2026- 2033, (USD Mn) o GCC Countries o Israel o Rest of Middle East o Africa  Market Share Analysis, By Country/Region, 2025, 2028 and 2033 (%)  Y-o-Y Growth Analysis, For Country/Region, 2021 - 2033  Market Size and Forecast, By Material Type, 2026- 2033, (USD Mn)  Market Size and Forecast, By Product Type, 2026- 2033, (USD Mn)  Market Size and Forecast, By Application, 2026- 2033, (USD Mn)  Market Size and Forecast, By End User, 2026- 2033, (USD Mn)  Market Size and Forecast, By Country, 2026- 2033, (USD Mn) o South Africa o North Africa o Central Africa 9. Competitive Landscape o Heat Map Analysis o Market Share Analysis (3x3 Matrix) o Company Profiles  Integra LifeSciences Corporation o Company Overview o Product Type Portfolio o Recent Developments/Updates  Smith & Nephew plc o Company Overview o Product Type Portfolio o Recent Developments/Updates  Organogenesis Inc. o Company Overview o Product Type Portfolio o Recent Developments/Updates  MiMedx Group, Inc. o Company Overview o Product Type Portfolio o Recent Developments/Updates  Avita Medical, Inc. o Company Overview o Product Type Portfolio o Recent Developments/Updates  Stratatech (a Mallinckrodt Company) o Company Overview o Product Type Portfolio o Recent Developments/Updates  Vericel Corporation o Company Overview o Product Type Portfolio o Recent Developments/Updates  B. Braun Melsungen AG o Company Overview o Product Type Portfolio o Recent Developments/Updates  Kerecis (Coloplast subsidiary) o Company Overview o Product Type Portfolio o Recent Developments/Updates  PolarityTE, Inc. o Company Overview o Product Type Portfolio o Recent Developments/Updates  Tissue Regenix Group plc o Company Overview o Product Type Portfolio o Recent Developments/Updates  Celularity o Company Overview o Product Type Portfolio o Recent Developments/Updates 10. Analyst Recommendation o Wheel of Fortune o Analyst View o Coherent Opportunity Map 11. Section o References o Research Methodology o About Us and Sales Contact

提及公司

Integra LifeSciences CorporationSmith & Nephew plcOrganogenesis Inc.MiMedx Group, Inc.Avita Medical, Inc.Stratatech (a Mallinckrodt Company)Vericel CorporationBraun Melsungen AGKerecis (Coloplast subsidiary)PolarityTE, Inc.Tissue Regenix Group plcCelularity

同分類最新報告(醫療器材)

常見問題

這份報告可以先索取樣本嗎?

可以。建議購買前先申請樣本,提出申請後約 2 個工作天內提供,您可以先確認內容涵蓋範圍是否符合需求。

報告價格如何計算?

報告以美元標價,台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本(單人/多人/企業全站)價格不同,量子訊息會評估您的使用情境後提供最優惠報價。

下單後多久交付?如何付款?

一般 3–7 個工作天交付,實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票,30 天內電匯付款即可。

量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理,提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們